Palforzia will almost certainly be the first treatment to get the green light for peanut allergy in Europe and its new owner will be hoping for a more successful launch than has been seen in the US.

Viteyes responds to pandemic; ChromaDex’ TruNiagen in Nestle Celltrient line extension; 7-Eleven goes sugar-free in energy with Triton; Nutrition21’s Velositol in MTS Outright Bar; Bhu Foods keto bars In Target, Walmart.

Consumer health companies are starting to step into the lucrative but fast-changing and complex EU cannabidiol market. But what are the key considerations for firms before making such a move, or if they have already? HBW Insight speaks to CBD regulatory expert Greer Deal. 

Private Company Edition: Also, Medicxi’s new €200m fund will be reinvested in a portfolio of six life science companies and Silverback more than doubled its 2020 money with an $85m series C round.